- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
September 16th, 2004
Mike Treder: This morning I went to a TV studio in Washington D.C. where I participated in the taping of a one-hour SAGE Crossroads program on the possibilities of using nanotechnology to combat disease and aging.
The main point I tried to make today is that unless policy questions concerning the potentially disruptive societal implications of nanotechnology -- political, economic, military, humanitarian, and environmental -- are decided well in advance, progress toward the implementation of anti-aging therapies might be delayed or halted. Disputes over such critical areas of interest could dwarf current controversies about biotechnology and genetic engineering.
|Related News Press|
PETA science consortium to present at Society for Risk Analysis meeting December 10th, 2014
Scientists disagree on responsible research April 8th, 2014